Intestinal Barrier Function and Neurodegenerative Disease

被引:4
作者
Wu, Shijing [1 ]
Yang, Liangfang [2 ]
Fu, Yiwei [1 ]
Liao, Zhimin [1 ]
Cai, De [3 ]
Liu, Zhou [1 ]
机构
[1] Guangdong Med Univ, Inst Neurol, Guangdong Key Lab Age Related Cardiac & Cerebral D, Dept Neurol,Affiliated Hosp, Zhanjiang 524001, Guangdong, Peoples R China
[2] Guangdong Med Univ, Affiliated Hosp, Dept Hepatobiliary Surg, Zhanjiang 524001, Guangdong, Peoples R China
[3] Guangdong Med Univ, Affiliated Hosp, Clin Skills Training Ctr, Zhanjiang 524001, Guangdong, Peoples R China
关键词
Neurodegenerative disease; Alzheimer's disease; Parkinson's disease; multiple sclerosis; intestinal barrier; gut-brain axis; gut microbiota; MULTIPLE-SCLEROSIS PATIENTS; INNATE LYMPHOID-CELLS; GUT MICROBIOTA; PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; SIGNALING PATHWAY; OXIDATIVE STRESS; PROTEIN; EXPRESSION; BRAIN;
D O I
10.2174/0118715273264097231116103948
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Neurodegenerative diseases are caused by the loss of neurons and/or their myelin sheaths, which deteriorate over time and become dysfunctional. Alzheimer's disease, Parkinson's disease, and multiple sclerosis are among the most prominent neurodegenerative diseases that affect millions of older adults worldwide. Despite extensive research over several decades, controversies still surround the etiology of neurodegenerative diseases, and many of them remain incurable. Meanwhile, an increasing number of new mechanistic studies related to the microbiota-gut-brain axis have emerged, among which the relationship between the function of the intestinal barrier and neurodegenerative diseases has received widespread attention. As one of the first lines of defense between the body and the external environment, the impaired function of the intestinal barrier is closely related to the development of neurodegenerative pathologies. Among them, the microbiota-gut-brain axis disorder characterized by intestinal barrier disruption mainly includes impaired function of the intestinal microbial barrier, chemical barrier, mechanical barrier, and immune barrier. This review focuses on the structure and molecular mechanisms of the various layers of the intestinal barrier as well as their relationship with neurodegenerative lesions. In recent years, intestinal barrier repair therapies have provided new ideas for the studied disease treatment modalities. We believe that a better understanding of the role of the intestinal barrier in neurodegenerative diseases would provide new insights for the development of viable therapeutic strategies for patients.
引用
收藏
页码:1134 / 1142
页数:9
相关论文
共 122 条
[1]   Focus on neurodegenerative disease [J].
不详 .
NATURE NEUROSCIENCE, 2018, 21 (10) :1293-1293
[2]   Active and passive involvement of claudins in the pathophysiology of intestinal inflammatory diseases [J].
Barmeyer, Christian ;
Fromm, Michael ;
Schulzke, Joerg-Dieter .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2017, 469 (01) :15-26
[3]   Effects of Resistant Starch on Symptoms, Fecal Markers, and Gut Microbiota in Parkinson's Disease - The RESISTA-PD Trial [J].
Becker, Anouck ;
Schmartz, Georges Pierre ;
Groeger, Laura ;
Grammes, Nadja ;
Galata, Valentina ;
Philippeit, Hannah ;
Weiland, Jacqueline ;
Ludwig, Nicole ;
Meese, Eckart ;
Tierling, Sascha ;
Walter, Jorn ;
Schwiertz, Andreas ;
Spiegel, Jorg ;
Wagenpfeil, Gudrun ;
Fassbender, Klaus ;
Keller, Andreas ;
Unger, Marcus M. .
GENOMICS PROTEOMICS & BIOINFORMATICS, 2022, 20 (02) :274-287
[4]   The importance of Wnt signalling for neurodegeneration in Parkinson's disease [J].
Berwick, Daniel C. ;
Harvey, Kirsten .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2012, 40 :1123-1128
[5]   Inflamm-aging: autoimmunity, and the immune-risk phenotype [J].
Boren, E ;
Gershwin, ME .
AUTOIMMUNITY REVIEWS, 2004, 3 (05) :401-406
[6]   The B-cell system of human mucosae and exocrine glands [J].
Brandtzaeg, P ;
Farstad, IN ;
Johansen, FE ;
Morton, HC ;
Norderhaug, IN ;
Yamanaka, T .
IMMUNOLOGICAL REVIEWS, 1999, 171 :45-87
[7]   The Contribution of Gut Barrier Changes to Multiple Sclerosis Pathophysiology [J].
Buscarinu, Maria Chiara ;
Fornasiero, Arianna ;
Romano, Silvia ;
Ferraldeschi, Michela ;
Mechelli, Rosella ;
Renie, Roberta ;
Morena, Emanuele ;
Romano, Carmela ;
Pellicciari, Giulia ;
Landi, Anna Chiara ;
Salvetti, Marco ;
Ristori, Giovanni .
FRONTIERS IN IMMUNOLOGY, 2019, 10
[8]   The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics [J].
Camara-Lemarroy, Carlos R. ;
Metz, Luanne ;
Meddings, Jonathan B. ;
Sharkey, Keith A. ;
Yong, V. Wee .
BRAIN, 2018, 141 :1900-1916
[9]   Interaction between Lipopolysaccharide and Gut Microbiota in Inflammatory Bowel Diseases [J].
Candelli, Marcello ;
Franza, Laura ;
Pignataro, Giulia ;
Ojetti, Veronica ;
Covino, Marcello ;
Piccioni, Andrea ;
Gasbarrini, Antonio ;
Franceschi, Francesco .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (12)
[10]   Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity [J].
Cani, Patrice D. ;
Osto, Melania ;
Geurts, Lucie ;
Everard, Amandine .
GUT MICROBES, 2012, 3 (04) :279-288